About R5 Pharmaceuticals
R5 Pharmaceuticals is a company based in Nottingham (United Kingdom) founded in 2006 was acquired by Aesica in June 2010.. R5 Pharmaceuticals has raised $494.31 thousand across 3 funding rounds from investors including Aesica. R5 Pharmaceuticals operates in a competitive market with competitors including Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others.
- Headquarter Nottingham, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of R5 Pharmaceuticals
R5 Pharmaceuticals has successfully raised a total of $494.31K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $28.85 thousand completed in November 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $28,850
-
First Round
First Round
(04 Apr 2007)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2011 | Amount | Grant - R5 Pharmaceuticals | Valuation |
investors |
|
| Jun, 2011 | Amount | Grant - R5 Pharmaceuticals | Valuation |
investors |
|
| Apr, 2007 | Amount | Seed - R5 Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in R5 Pharmaceuticals
R5 Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Aesica. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by R5 Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - R5 Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
R5 Pharmaceuticals Comparisons
Competitors of R5 Pharmaceuticals
R5 Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about R5 Pharmaceuticals
When was R5 Pharmaceuticals founded?
R5 Pharmaceuticals was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is R5 Pharmaceuticals located?
R5 Pharmaceuticals is headquartered in Nottingham, United Kingdom.
Is R5 Pharmaceuticals a funded company?
R5 Pharmaceuticals is a funded company, having raised a total of $494.31K across 3 funding rounds to date. The company's 1st funding round was a Seed of $494.31K, raised on Apr 04, 2007.
What does R5 Pharmaceuticals do?
R5 Pharmaceuticals was established in 2006 in Nottingham, United Kingdom, within the pharmaceutical sector. GMP facilities were operated to produce dosage forms such as tablets, capsules, creams, ointments, and injectables, supported by an analytical laboratory for method development, quality control, and stability testing. Services were provided for formulating and analyzing synthetic and biotech materials, including cytotoxic APIs, proteins, and peptides. The company was acquired by Aesica in July 2010.
Who are the top competitors of R5 Pharmaceuticals?
R5 Pharmaceuticals's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Who are R5 Pharmaceuticals's investors?
R5 Pharmaceuticals has 1 investor. Key investors include Aesica.